Evidence map›Paper›PMID 35094088›Full record

ArticleHuman molecular genetics2022

NSD1 mutations deregulate transcription and DNA methylation of bivalent developmental genes in Sotos syndrome.

Kevin Brennan, Hong Zheng, Jill A Fahrner, June Ho Shin, Andrew J Gentles, Bradley Schaefer, John B Sunwoo, Jonathan A Bernstein, Olivier Gevaert

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Kevin BrennanStanford Center for Biomedical Informatics Research, Department of Medicine, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0001-9018-9852
Hong ZhengStanford Center for Biomedical Informatics Research, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
Jill A FahrnerDepartment of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
June Ho ShinDepartment of Otolaryngology - Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, CA 94305, USA.
Andrew J GentlesStanford Center for Biomedical Informatics Research, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
Bradley SchaeferDepartment of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
John B SunwooDepartment of Otolaryngology - Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, CA 94305, USA.
Jonathan A BernsteinDepartment of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA.
Olivier GevaertStanford Center for Biomedical Informatics Research, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
Stanford Medicine · USStanford University · USJohns Hopkins University · USUniversity of Arkansas for Medical Sciences · US

Funding

Sleep and Circadian Dysfunction, Brain and Neurobehavioral Development in AutismP50HD103538 · NICHD · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI Stewart H Mostofsky · 2020 to 2026
$9.9M
Exploring Disrupted H3K27me3 in Mendelian Disorders of the Epigenetic Machinery and Restoring Its Balance as a Therapeutic Approach to Treat Abnormal GrowthK08HD086250 · NICHD · JOHNS HOPKINS UNIVERSITY · PI FAHRNER, JILL A · 2018 to 2023
$966k
NICHD NIH HHS K08 HD086250NICHD NIH HHS P50 HD103538NIH HHS K08HD086250
6 · The paper itself

Abstract

Sotos syndrome (SS), the most common overgrowth with intellectual disability (OGID) disorder, is caused by inactivating germline mutations of NSD1, which encodes a histone H3 lysine 36 methyltransferase. To understand how NSD1 inactivation deregulates transcription and DNA methylation (DNAm), and to explore how these abnormalities affect human development, we profiled transcription and DNAm in SS patients and healthy control individuals. We identified a transcriptional signature that distinguishes individuals with SS from controls and was also deregulated in NSD1-mutated cancers. Most abnormally expressed genes displayed reduced expression in SS; these downregulated genes consisted mostly of bivalent genes and were enriched for regulators of development and neural synapse function. DNA hypomethylation was strongly enriched within promoters of transcriptionally deregulated genes: overexpressed genes displayed hypomethylation at their transcription start sites while underexpressed genes featured hypomethylation at polycomb binding sites within their promoter CpG island shores. SS patients featured accelerated molecular aging at the levels of both transcription and DNAm. Overall, these findings indicate that NSD1-deposited H3K36 methylation regulates transcription by directing promoter DNA methylation, partially by repressing polycomb repressive complex 2 (PRC2) activity. These findings could explain the phenotypic similarity of SS to OGID disorders that are caused by mutations in PRC2 complex-encoding genes.

Indexed as

Sotos SyndromeDNA MethylationGenes, DevelopmentalHistone-Lysine N-MethyltransferaseHistone MethyltransferasesHumansMutationHistone-Lysine N-MethyltransferaseHistone MethyltransferasesNSD1 protein, human

Identifiers

PMID35094088
PMCPMC9262396
OpenAlexW4206964157

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.